"First in the world": on August 12, Russia will register a vaccine against COVID-19

Russian vaccine developed by the National Research Center for Epidemiology and Microbiology named after N.F. Gamalei, will be registered next week. Deputy Minister of Health Oleg Gridnev announced this during his visit to Ufa.

"Registration of the vaccine developed in the center of Gamaleya will be on August 12 ... The first to be vaccinated will be medical workers and the elderly," said Gridnev.

According to Gridnev, the drug is currently at the final stage of registration. Clinical trials data and other necessary documents are under examination. The deputy minister stressed the need for the vaccine to be safe.

"Russia will be the first in the world to register a vaccine against coronavirus," the Moscow operational headquarters emphasized

The head of the Gamaleya Center, Alexander Gintsburg, in an interview with the Russia-24 TV channel, stressed that vaccination against coronavirus cannot cause COVID-19 disease.

“These particles, with which we vaccinate the body, are made on adenovirus, they are not alive. Those particles, those objects that can reproduce their own kind are alive, ”the specialist said.

"These particles cannot multiply, so there is simply no reason to fear that they can do something bad in our body," added Gunzburg.

Virologist, doctor of medical sciences, professor at the Gamaleya Center for Epidemiology and Microbiology Viktor Zuev, in an interview with RT, emphasized the importance of the work carried out by specialists.

“This is so important that it is not even negotiable. Suffice it to say that the whole world is waiting for the vaccine. And in our country, moreover, in our center, where I have the honor to work for sixty years without interruption, this vaccine was made the first, ”Zuev said.

Recall that on July 20, a second group of volunteers who tested the COVID-19 vaccine were discharged from the Burdenko Main Military Clinical Hospital and Sechenov University. It is reported that the use of the drug did not lead to complications, the vaccinated developed antibodies to the virus. On August 3, the Russian Ministry of Defense reported that according to the results of the final examination of volunteers, one can speak of "the safety and good tolerance of the vaccine."

• vk.com
• © covid2019_official

Commenting on the message about the imminent registration of the coronavirus vaccine, the head of the Department of Economics, Management and Evaluation of Health Technology at the Russian Medical Academy of Continuing Professional Education, Vitaly Omelyanovsky, in an interview with RT, expressed the hope that the drug will show its effectiveness and be safe.

“Of course, it's great if a vaccine is registered in Russia. Russia will demonstrate that we have science and political will, and the state cares about the population, ”Omelyanovsky said.

First Deputy Chairman of the State Duma Health Protection Committee Fedot Tumusov called the prompt completion of work on one of the coronavirus vaccines a positive signal, which suggests that Russian science - both medical and biological - is at the forefront.

“The most important issue for a vaccine is its effectiveness and safety. I understand that the effectiveness has already been identified. But I am convinced that our scientists and medical industry leaders are very attentive to this issue. Therefore, on the one hand, this is very good news, but on the other, we must understand that the security issue requires a long-term check, "said the interlocutor of RT.

In turn, the deputy chairman of the State Duma Committee on Health Protection Leonid Ogul called it logical that the Russian side was the first to approach the final stages of work on the COVID-19 vaccine.

“I can say that initially both the legislators, and vaccine prophylaxis, and immunoprophylaxis said that Russia has a very good scientific potential. Therefore, I believe that everything is natural here. Of course, there is no need to arrange a competition here. First of all, the quality of this vaccine and the effect it will produce are important. There are two important factors to pay attention to, ”he added.

Anti-COVID-19 drug

On the eve of the Federal Medical and Biological Agency (FMBA) patented the domestic drug Leitragin, which can prevent or mitigate the complications caused by coronavirus infection.

“This is the first and the only agonist of delta-opioid receptors in the world to this day, which has entered practical medicine,” the FMBA reported.

Domestic development was made on the basis of the drug "Dalargin", which was previously used to treat stomach ulcers, acute pancreatitis and pancreatic necrosis.

"During the research, they confirmed that Leitragin is able to prevent or mitigate the" cytokine storm "- a massive release of pro-inflammatory substances leading to the development of severe respiratory and general systemic disorders in a patient with a new coronavirus infection," explained the head of the FMBA, Veronika Skvortsova.

• AFP
• © Kirill KUDRYAVTSEV

New cases

Over the past day, 5241 new cases of COVID-19 were detected in 84 regions of Russia. According to the headquarters, 27.1% of new patients had no clinical manifestations of infection. In the two days preceding this, 5267 and 5204 cases of coronavirus were recorded.

The regions where the largest number of new cases were detected per day included Moscow (686), Sverdlovsk (180) and Moscow (158) regions, St. Petersburg (157) and Khanty-Mansi Autonomous Okrug (143).

Since the beginning of the epidemic, 683,592 patients (77.93%) have recovered in Russia, including 7,235 in the last day. From complications that developed against the background of coronavirus infection and concomitant diseases, 14,725 patients (1.68%) have died in the country for the entire time. During the day, 119 people died.

In total, in Russia, the diagnosis of COVID-19 was confirmed in 877,135 people, more than a quarter of the detected cases were in Moscow (245,740). According to Johns Hopkins University, according to this indicator, the Russian Federation is in fourth place in the world. The largest number of cases was recorded in the United States (almost 4.9 million), Brazil (2.9 million) and India (2 million).

Worldwide, the number of detected cases exceeded 19 million. More than 715 thousand people died from complications that developed against the background of COVID-19 and concomitant diseases. Of these, more than 160 thousand people - in the United States, almost 98.5 thousand - in Brazil and 50.5 thousand - in Mexico.